GOREISAN for Heart Failure (GOREISAN-HF) Trial

Clinical trial NCT04691700 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04691700
Sponsor: Takeshi Morimoto
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Heart Failure Edema Traditional Japanese Medicine Kampo Medicine Clinical Trial

Start date: 2021-01-19
Primary completion: 2027-12-31
Enrollment: 1179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.